Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome

Stopped early

Conditions studied: Hypercortisolism, Cushing Syndrome

In brief

This retrospective, multi-center, chart review study will collect patient data from medical charts of pediatric patients who have been treated with Korlym for Cushing's syndrome.

Key facts

Study ID

NCT03379363

Run by

Corcept Therapeutics

People needed

2

Starts

2017-09-18

Expected to finish

2018-02-12

Last updated by the study team

2019-07-30

Who can join

Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Pediatrics (age≤21 years) at time Korlym initiation
• Considered to have a diagnosis of endogenous Cushing's syndrome by the healthcare provider
• Received at least one dose of Korlym
• Availability of pre-treatment (baseline) and follow-up data

You may not qualify if…

• None

Where it is running

• Corcept Therapeutics — Menlo Park, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.